Discover our robust scientific pipeline. Dhanova Healthcare is dedicated to developing high-quality, innovative formulations across General Medicine, Neurology, and Cardiovascular Care to meet critical patient needs.
Target identification and extensive laboratory testing. Evaluating new chemical entities (NCEs) for initial safety, stability, and therapeutic efficacy in cell models.
First-in-human testing conducting safety assessments on small groups of healthy volunteers. Focuses primarily on tolerability, pharmacokinetics, and safe dosing scales.
Testing the drug on a larger cohort of patient volunteers suffering from specific conditions (e.g., Hypertension, Chronic Neuropathy) to validate clinical performance.
Large-scale multi-centric trials to confirm therapeutic benefit, monitor side effects in diverse populations, and compare efficiency against standard existing treatments.
Submission of comprehensive technical dossiers and New Drug Applications (NDA) to regulatory authorities like DCGI for review and marketing authorization permissions.
Continuous pharmacovigilance and surveillance after commercial rollout to evaluate long-term safe usability, drug interactions, and optimizing production scales.
© Copyright 2026 Dhanova Healthcare Pvt. Ltd. All Rights Reserved.